C-reactive protein: FCR receptor-mediated effects on human peripheral blood basophils in vitro

Basophil Granulocytes

Volumn , Issue , 2011, Pages 92-121

  Nazarov, Peter G ^a   Pronina, Anastasia P ^a   Trulioff, Andrey S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892062778     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (51)

1. Beekman, JM; Bakema, JE; van de Winkel, JG; Leusen, JH. Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(28), 10392-10397.
2. Bharadwaj, D; Mold, C; Markham, Ye; Du Clos, TW. Serum amyloid P component binds to Fcg receptors and opsonizes particles for phagocytosis. J. Immunol., 2001, 166(11), 6735-6741.
3. Bharadwaj, D; Stein, MP; Volzer, M; Mold, C; Du Clos, TW. The major receptor for C-reactive protein on leukocytes is Fcgamma receptor II. J. Exp. Med., 1999, 190(4), 585-590.
4. Bühring, HJ; Streble, A; Valent, P. The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int. Arch. Allergy Immunol., 2004, 133(4), 317-329.
5. Devaraj, S; Davis, B; Simon, SI; Jialal, I. CRP promotes monocyte-endothelial cell adhesion via Fc-gamma receptors in human aortic endothelial cells under static and shear flow conditions. Am. J. Physiol. Heart Circ. Physiol., 2006, 291(3), H1170-H1176.
6. Devaraj, S; Du Clos, TW; Jialal, I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler. Thromb. Vasc. Biol., 2005, 26(7), 1359-1363.
7. Du Clos, TW; Mold, C. C-reactive protein an activator of innate immunity and a modulator of adaptive immunity. Imm. Res., 2004, 30(3), 261-277.
8. Du Clos, TW; Mold, C. The role of C-reactive protein in the resolution of bacterial infection. Curr. Opin. Inf. Dis., 2001, 14(3), 289-293.
9. Dvorak, AM; Colvin, RB; Monahan, RA. Immunoferritin electron microscopic studies with antibasophil serum of guinea pig basophil degranulation and regranulation in vitro. Clin. Immunol. Immunopathol., 1985, 37(1), 63-76.
10. Dvorak, AM; Galli, SJ; Morgan, E; Galli, AS; Hammond, ME; Dvorak, HF. Anaphylactic degranulation of guinea pig basophilic leukocytes. II. Evidence for regranulation of mature basophils during recovery from degranulation in vitro. Lab. Invest., 1982, 46(5), 461-475.
11. Falcone, FH; Zillikens, D; Gibbs, BF. The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp. Dermatol., 2006, 15(11), 855-864.
12. Fujimoto, T; Sato, Y; Sasaki, N; Teshima, R; Hanaoka, K; Kitani, S. The canine mast cell activation via CRP. Biochem. Biophys. Res. Commun., 2003, 301(1), 212-217.
13. Grützkau, A; Smorodchenko, A; Lippert, U; Kirchhof, L; Artuc, M; Henz, BM. LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry A., 2004, 61(1), 62-68.
14. Gupta, N; Scharenberg, AM; Fruman, DA; Cantley, LC; Kinet, JP; Long, EO. The SH2 domain-containing inositol 5-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgRIIb1-mediated Inhibition of B cell receptor signaling. J. Biol. Chem., 1999, 274(11), 7489-7494.
15. Horowitz, J; Volanakis, JE; Briles, DE. Blood clearance of Streptococcus pneumoniae by C-reactive protein. J. Immunol., 1987, 138(8), 2598-2603.
16. Ikuta, T; Okubo, H; Ishibashi, H; Okumura, Y; Hayashida, K. Human lymphocytes synthesize C-reactive protein. Inflammation., 1986, 10(3), 223-232.
17. Jensen, AA; Mikkelsen, I; Frølund, B; Bräuner-Osborne, H; Falch, E; Krogsgaard-Larsen, P. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors. Mol. Pharmacol., 2003, 64(4), 865-875.
18. Katz, HR. Inhibitory receptors and allergy. Curr. Opin. Immun., 2002, 14(6), 698-704.
19. Kawashima, K; Fujii, T. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther., 2000, 86(1), 29-48.
20. Kirkpatrick, CJ; Bittinger, F; Nozadze, K; Wessler, I. Expression and function of the non-neuronal cholinergic system in endothelial cells. Life Sci., 2003, 72(18-19), 2111-2116.
21. Knol, EF; Mul, FP; Jansen, H; Calafat, J; Roos, D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J. Allergy Clin. Immunol., 1991, 88(3 Pt 1), 328-338.
22. Lange, A; Karabon, L; Tomeczko, J. IL-6-and IL-4-related proteins (C-reactive protein and IgE) are prognostic factors of asbestos-related cancer. Ann. N.Y. Acad. Sci., 1995, 762, 435-438.
23. Liang, YJ; Shyu, KG; Wang, BW; Lai, LP. C-reactive protein activates the nuclear factor-κB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. J. Mol. Cell., Cardiol. 2006, 40(3), 412-420.
24. Marnell, LL; Mold, C; Volzer, MA; Burlingame, RW; Du Clos, TW. C-reactive protein binds to Fc gamma RI in transfected COS cells. J. Immunol., 1995, 155(4), 2185-2193.
25. Metzelaar, MJ; Wijngaard, PL; Peters, PJ; Sixma, JJ; Nieuwenhuis, HK; Clevers, HC. CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J. Biol. Chem., 1991, 266(5), 3239-3235.
26. Mineo, C; Gormley, AK; Yuhanna, IS; Osborne-Lawrence, S; Gibson, LL; Hahner, L; Shohet, RV; Black, S; Salmon, JE; Samols, D; Karp, DR; Thomas, GD; Shaul, PW. FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ. Res., 2005, 97(11), 1124-1131.
27. Mohamed, HA; Mosier, DR; Zou, LL; Siklós, L; Alexianu, ME; Engelhardt, JI; Beers, DR; Le, WD; Appel, SH. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. J. Neurosci. Res., 2002, 69(1), 110-116.
28. Mold, C; Gresham, HD; Du Clos, TW. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcgRs. J. Immunol., 2001, 166(2), 1200-1205.
29. Nakayama, S; Du Clos, TW; Gewurz, H; Mold, C. Inhibition of antibody responses to phosphocholine by C-reactive protein. J. Immunol., 1984, 132(3), 1336-1340.
30. Nazarov, PG. Reactants of Acute Phase of Inflammation. 2001, Nauka, St. Petersburg. 423 (In Russian).
31. Nazarov, PG; Krylova, IB; Evdokimova, NR; Nezhinskaya, GI; Butyugov, AA. C reactive protein: a factor of inflammation binding and inactivating acetylcholine. Cytokines and Inflammation., 2006, 6(4), 32-35. (in Russian).
32. Nazarov, PG; Krylova, IB; Evdokimova, NR; Nezhinskaya, GI; Butyugov, AA. C-reactive protein: a pentraxin with anti-acetylcholine activity. Life Sci., 2007, 80(24-25), 2337-2341.
33. Nazarov, PG; Nezhinskaya, GI; Krylova, IB. Pentraxins: antiarrhythmogenic factors of inflammation. Ann. Arrhythmol., 2005, 2(suppl), 20.
34. Nazarov, PG; Sofronov, BN. Synthesis of C-reactive protein by lymphoid cells. In: Mediators of Immune Response in Experiments and Clinics. Institute of Immunology, USSR Ministry of Health, Moscow, 1983, 112-113. (In Russian).
35. Nezhinskaya, GI; Losev, NA; Nazarov, PG; Sapronov, NS. Effect of acetylcholine and C-reactive protein on regulation of anaphylactic shock in guinea pigs. Eksp. Klin. Farmakol., 2005, 68(4), 49-52. (In Russian)
36. Nezhinskaya, GI; Nazarov, PG; Evdokimova, NR; Losev, NA; Sapronov, NS. Cholinergic regulation of anaphylactic shock: impact of C-reactive protein. Cytokines and Inflammation., 2004, 3(1), 39-41. (in Russian).
37. Nieuwenhuis, HK; van Oosterhout, JJ; Rozemuller, E; van Iwaarden, F; Sixma, JJ. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood., 1987, 70(3), 838-845.
38. Oishi, K; Yoshizumi, T; Seki, N; Uchida, MK. Carbachol-induced membrane ruffling and Its desensitization in rat basophilic leukemia (RBL-2H3) cells transfected with m3 muscarinic acetylcholine receptors. Biol. Pharm. Bull., 2004, 27(10), 1544-1548.
39. Picciotto, MR; Addy, NA; Mineur, YS; Brunzell, DH. It is not-either/or: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog. Neurobiol., 2008, 84(4), 329-342.
40. Ravetch, JV; Bolland, S. IgG Fc receptors. Annu Rev Immunol., 2001, 19, 275-290.
41. Suresh, MV; Singh, SK; Agrawal, A. Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J. Biol. Chem., 2004, 279(50), 52552-52557.
42. Suzuki, K; Kitani, S; Takaishi, T; Ito, K; Ra, C; Morita, Y. Nonreleasing basophils convert to releasing basophils by culturing with IL-3. J. Allergy Clin. Immunol., 1996, 97(6), 1279-1287.
43. Szalai, AJ; Briles, DE; Volanakis, JE. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol., 1995, 155(8), 2557-2563.
44. Tseng, J; Mortensen, RF. Binding of human C-reactive protein (CRP) to plasma fibronectin occurs via the phosphorylcholine-binding site. Mol. Immunol., 1988, 25(8), 679-686.
45. Tseng, J; Mortensen, RF. The effect of human C-reactive protein on the cell-attachment activity of fibronectin and laminin. Exp. Cell Res., 1989, 180(2), 303-313.
46. Van de Winkel, JG; Capel, PJ. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today., 1993, 14(5), 215-221
47. Van de Winkel, JGJ; Anderson, CL. Biology of human immunoglobulin G Fc receptors. J. Leukoc. Biol., 1991, 49(5), 511-524.
48. Wessler, I; Kilbinger, H; Bittinger, F; Unger, R; Kirkpatrick, CJ. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci., 2003, 72(18-19), 2055-2061.
49. Wigginton, SJ; Furtado, PB; Armour, KL; Clark, MR; Robins, A; Emara, M; Ghaemmaghami, AM; Sewell, HF; Shakib, F. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb. Clin. Exp. Allergy., 2008, 38(2), 313-319.
50. Xiao, Y; Kellar, K J. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. J. Pharmacol. Exp. Ther., 2004, 310(1), 98-107.
51. Zhang, D; Sun, M; Samols, D; Kushner, I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem., 1996, 271(16), 9503-9509.